Nearly 400,000 new cases of congestive heart failure or CHF are reported in the United States each year. The most common interventional treatment, the heart transplant procedure, can only be offered to 2,000 patients annually due to a shortage of donor organs. The Arizona Heart Foundation is the world leader in myoblast cell research, in which cells are extracted from a patient's own biceps or thigh skeletal muscle and then cultured in a laboratory where millions are grown. The cells are then injected into dead heart muscle where they take on the characteristics of new cardiac muscle cells.

© 2003-2009 Arizona Heart Foundation
Designed and developed by VAS Communications